Healthcare Software Articles & Analysis
22 news found
We are delighted to welcome Roczen to the community of healthcare organisations leveraging Vantage Software! We look forward to working together and helping them deliver exceptional care and support to those living with chronic conditions. ...
Vantage is LFPSE Compliant! We are thrilled to announce that Vantage, has successfully passed NHS England’s rigorous LFPSE (Learning from Patient Safety Events) compliance testing and are officially recognised as an accredited LFPSE supplier. This accreditation is a testament to our commitment to enhancing patient safety in healthcare organisations across the nation. With the ...
Iterative Scopes, a pioneer in precision medicine technologies for gastroenterology, and Provation, the premier software and SaaS provider of clinical productivity and workflow automation solutions, announced today that SKOUT™ has received 510(k) clearance from the U.S. ...
BOSTON – July 26, 2022 – Elucid, a novel non-invasive software company providing physicians with AI-powered imaging to characterize cardiovascular disease, is pleased to announce that Todd C. ...
ByElucid
The Elucid platform is the only FDA-Cleared and CE-Marked software to objectively quantify plaque morphology validated against tissue specimens. ...
ByElucid
(Nasdaq: LUCD) (“Lucid”), a commercial-stage cancer prevention medical diagnostics company, today announced that PAVmed and Lucid Chairman & Chief Executive Officer Lishan Aklog, M.D. was selected as one of the Top 50 Healthcare Technology CEOs of 2022 by The Healthcare Technology Report. ...
” The ElucidVivo software demonstrated a 40% improvement in predictive accuracy for these events, primarily stroke. ...
ByElucid
QView Medical, a breast cancer detection pioneer and maker of the FDA-approved artificial intelligence (AI) software system for breast cancer screening, and GE Healthcare today announced that QView's QVCAD software can be launched on GE Healthcare's Invenia™ ABUS 2.0 (Automated Breast Ultrasound), which has an open platform ...
BOSTON–(BUSINESS WIRE)–Elucid, a medical technology company developing AI software to enable cardiovascular disease detection, expects newly issued guidelines will be a catalyst for non-invasive image, revolutionizing the way patients with coronary artery disease are diagnosed and treated. ...
ByElucid
Prior to utilizing Elucid’s AI software, CTA has been increasingly used in the diagnosis of vascular disease. ...
ByElucid
About IDEXX Laboratories IDEXX Laboratories, Inc. is a member of the S&P 500® Index and is a leader in pet healthcare innovation, offering diagnostic and software products and services that deliver solutions and insights to practicing veterinarians around the world. ...
BOSTON – Elucid, a medical technology company developing AI software to enable cardiovascular disease detection, today announced $8 Million in Series A financing led by MedTex Ventures and Global Health Impact Fund. ...
ByElucid
The presentation, entitledEffect of Icosapent Ethyl (IPE) on Changes in Coronary Plaque Morphology, details the effects of IPE on cardiovascular events and plaque characteristics using the ElucidVivo software on CT angiography (CTA). The ElucidVivo software is the first and only FDA-cleared arterial analysis tool designed to quantify morphology from CTA as if ...
ByElucid
Sensegain Group is headquartered in Beijing with multiple locations globally and has developed a strong partnership with industry leaders, as well as deep insights into sectors including TMT, Healthcare, and Advanced Manufacturing in China, United States, Canada, Israel, and other countries. ...
VIDA’s growing recognition as a leader in AI-based imaging is founded on its suite of software solutions, which empower healthcare organizations and physicians in the fight against lung and respiratory disease. In the first half of 2020, VIDA has been recognized as a leader in AI for healthcare by Forbes, Frost & Sullivan, ...
Addressing contamination control for our healthcare facilities becomes ground zero in preventing and controlling an outbreak. ...
Using artificial intelligence (AI) to analyze breast ultrasound lesions reduced interpretation time by 49% at a healthcare center in Missouri. The software is particularly helpful for lesions classified as BI-RADS 2, 3, and 4A, attendees of the Society for Imaging Informatics in Medicine’s (SIIM) virtual meeting learned on June 24. For almost a year, the ...
USVP has invested in over 400 companies spanning four decades, including: Box, Check Point Software, Guidewire, HeartFlow, HotelTonight, Imperva, Inari Medical, Inspire Medical Systems, Intersect ENT, Luminate, Omada Health, Pluto TV, Prevoty, Sequent, ThreatMetrix, Trunk Club, Trusteer, Vontu, Yammer and Zerto. USVP focuses on early-stage start-ups that transform cybersecurity, ...
Fourth straight year in which the prestigious healthcare research firm selects PharmacyKeeper Verification as the No. 1 Category Leader for Intravenous (IV) Workflow Management PharmacyKeeper Verification is a strategic part of Grifols’ inclusiv portfolio, offering integrated technology, software and service solutions dedicated to advancing quality and ...
Third Pole Therapeutics, a privately held company developing and delivering transformative life-saving cardio-pulmonary therapies, has named seasoned healthcare executive Bill Athenson as its new Chief Executive Officer, the company announced today. ...
